Get comprehensive HLA DSA Donor Specific IgG Antibodies Class I & II testing for $326 USD in USA. Essential pre-transplant screening detects donor-specific antibodies using Luminex technology. Available in New York
Sale!

HLA DSA Donor Specific IgG Antibodies Class I & II Test

Original price was: $450.Current price is: $326.

-28%

The HLA DSA Donor Specific IgG Antibodies Class I & II Test is a critical pre-transplant screening tool that detects donor-specific antibodies in transplant recipients. This advanced diagnostic test identifies IgG antibodies targeting HLA Class I and II antigens, which can cause organ rejection. Using Luminex X-Map technology, the test provides highly sensitive detection of antibodies that may compromise transplant success. Patients undergoing kidney, heart, liver, or other organ transplants benefit from this essential screening. The test costs $326 USD and helps prevent antibody-mediated rejection, improving transplant outcomes and patient survival rates. Results are available within 10-12 days from blood or serum samples collected 48 hours post-dialysis when applicable.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

HLA DSA Donor Specific IgG Antibodies Class I & II Test

Comprehensive Introduction to HLA DSA Testing

The HLA DSA Donor Specific IgG Antibodies Class I & II Test represents a cornerstone in modern transplant medicine, providing essential immunological assessment for patients undergoing organ transplantation. This sophisticated diagnostic tool detects donor-specific antibodies that could potentially trigger rejection episodes, making it indispensable for transplant success and long-term graft survival.

What Does This Test Measure?

This advanced immunological assay specifically identifies IgG antibodies directed against Human Leukocyte Antigen (HLA) Class I and Class II molecules from potential organ donors. The test utilizes cutting-edge Luminex X-Map technology to provide:

  • Detection of donor-specific HLA antibodies
  • Quantification of antibody strength and specificity
  • Identification of both Class I (HLA-A, B, C) and Class II (HLA-DR, DQ, DP) antibodies
  • Assessment of immunological risk for transplant rejection

Who Should Consider HLA DSA Testing?

Primary Candidates Include:

  • Patients awaiting kidney, heart, liver, or other organ transplantation
  • Individuals with previous transplant history
  • Patients with blood transfusions or pregnancy history
  • Recipients being evaluated for living donor transplants
  • Patients experiencing unexplained transplant dysfunction

Clinical Indications:

  • Pre-transplant compatibility assessment
  • Post-transplant monitoring for antibody-mediated rejection
  • Evaluation of sensitized patients
  • Assessment of immunological risk stratification

Significant Benefits of HLA DSA Testing

This comprehensive antibody screening offers multiple advantages for transplant candidates and recipients:

  • Enhanced Transplant Success: Identifies potential rejection risks before transplantation
  • Personalized Treatment Planning: Guides immunosuppression strategies
  • Improved Patient Outcomes: Reduces incidence of antibody-mediated rejection
  • Long-term Graft Survival: Supports better organ function over time
  • Risk Stratification: Helps clinicians make informed decisions about transplant timing and donor selection

Understanding Your Test Results

Interpretation Guidelines:

Your HLA DSA test results will provide detailed information about antibody presence and strength:

  • Negative Results: Indicate no detectable donor-specific antibodies, suggesting lower rejection risk
  • Positive Results: Show presence of donor-specific antibodies requiring careful clinical evaluation
  • Antibody Strength: Measured in Mean Fluorescence Intensity (MFI) values
  • Clinical Correlation: Results must be interpreted by your transplant specialist in context of your medical history

Next Steps Based on Results:

  • Discuss findings with your nephrologist or transplant team
  • Consider additional desensitization protocols if needed
  • Plan appropriate immunosuppression regimens
  • Schedule follow-up testing as recommended

Test Pricing Information

Test Description Price (USD)
HLA DSA Donor Specific IgG Antibodies Class I & II Test – Discount Price $326
HLA DSA Donor Specific IgG Antibodies Class I & II Test – Regular Price $450

Important Pre-Test Instructions

For accurate results, please follow these essential guidelines:

  • Collect specimen preferably 48 hours after dialysis (when applicable)
  • Provide doctor’s prescription on official letterhead with stamp
  • Submit 1 photograph each of recipient and donor
  • Sample types: Blood or Serum
  • Turnaround time: 10-12 days

Nationwide Testing Availability

GGC DNA provides comprehensive HLA DSA testing services across the United States. We have established branches in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, and numerous other cities nationwide. Our network ensures convenient access to this critical transplant screening test regardless of your location.

Book Your HLA DSA Test Today

Take the crucial step toward successful transplantation with our comprehensive HLA DSA antibody screening. Our experienced team and advanced Luminex technology ensure accurate, reliable results you can trust for your transplant journey.

Call or WhatsApp us now at +1(267) 388-9828 to schedule your test or speak with our transplant specialists.

Don’t leave your transplant success to chance – secure your immunological assessment with GGC DNA’s premier HLA DSA testing services today.

SKU: 1172 Category: